{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:24:24Z","timestamp":1791915864618,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 97917"],"award-info":[{"award-number":["MOP 97917"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Science and Technology Committee, China","award":["14JC1492300"],"award-info":[{"award-number":["14JC1492300"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM089820"],"award-info":[{"award-number":["GM089820"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.gene.2016.04.031","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T16:07:28Z","timestamp":1461341248000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Current knowledge of the multifunctional 17\u03b2-hydroxysteroid dehydrogenase type 1 (HSD17B1)"],"prefix":"10.1016","volume":"588","author":[{"given":"Wanhong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-4174","authenticated-orcid":false,"given":"Misra","family":"Gauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6622-9471","authenticated-orcid":false,"given":"Tang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Xiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2016.04.031_bb0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejmech.2014.05.074","article-title":"Inhibition of 17\u03b2-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker","volume":"82","author":"Abdelsamie","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.gene.2016.04.031_bb0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1210\/me.2009-0468","article-title":"17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production","volume":"24","author":"Aka","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mce.2008.10.042","article-title":"Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer","volume":"301","author":"Aka","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.gene.2016.04.031_bb0020","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/bcr3207","article-title":"17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration","volume":"14","author":"Aka","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2005.12.004","article-title":"Active site analysis of 17beta-hydroxysteroid dehydrogenase type 1 enzyme complexes with SPROUT","volume":"248","author":"Alho-Richmond","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10","key":"10.1016\/j.gene.2016.04.031_bb0030","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1535-7163.MCT-12-0299","article-title":"A new nonestrogenic steroidal inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type I blocks the estrogen-dependent breast cancer tumor growth induced by estrone","volume":"11","author":"Ayan","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.gene.2016.04.031_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nsb0896-665","article-title":"Crystal structure of human estrogenic 17\u03b2-hydroxysteroid dehydrogenase complexed with 17\u03b2-estradiol","volume":"3","author":"Azzi","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.gene.2016.04.031_bb0040","series-title":"Hormone-dependent Cancer","first-page":"155","article-title":"Pharmacology of nonsteroidal aromatase inhibitors","author":"Batzl","year":"1996"},{"issue":"12","key":"10.1016\/j.gene.2016.04.031_bb0045","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1158\/1055-9965.EPI-07-0542","volume":"16","author":"Beesley","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"21","key":"10.1016\/j.gene.2016.04.031_bb0050","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1021\/jm901195w","article-title":"New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitory activity and selectivity","volume":"52","author":"Bey","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.gene.2016.04.031_bb0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0969-2126(96)00098-6","article-title":"The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors","volume":"4","author":"Breton","year":"1996","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/092986708783330629","article-title":"Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1","volume":"15","author":"Brozic","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.gene.2016.04.031_bb0065","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1073\/pnas.70.11.3052","article-title":"D-glyceraldehyde-3-phosphate dehydrogenase: three-dimensional structure and evolutionary significance","volume":"70","author":"Buehner","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8\u20139","key":"10.1016\/j.gene.2016.04.031_bb0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.steroids.2009.10.007","article-title":"Cell proliferation regulated by estradiol receptor: therapeutic implications","volume":"75","author":"Castoria","year":"2010","journal-title":"Steroids"},{"issue":"16","key":"10.1016\/j.gene.2016.04.031_bb0075","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/MCB.24.16.7260-7274.2004","volume":"24","author":"Cicatiello","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"9 Suppl 1","key":"10.1016\/j.gene.2016.04.031_bb0080","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.amjmed.2006.07.007","article-title":"Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors","volume":"119","author":"Crandall","year":"2006","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.gene.2016.04.031_bb0085","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1158\/1055-9965.EPI-06-0767","article-title":"Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer","volume":"16","author":"Cunningham","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"9","key":"10.1016\/j.gene.2016.04.031_bb0090","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ijc.23350","article-title":"17beta-hydroxysteroid dehydrogenase type 1, and not type 12, is a target for endocrine therapy of hormone-dependent breast cancer","volume":"122","author":"Day","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.gene.2016.04.031_bb0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1677\/ERC-08-0042","article-title":"Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis","volume":"15","author":"Day","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb1000","first-page":"87","article-title":"17\u00df-hydroxysteroid dehydrogenase inhibitors","volume":"35","author":"Day","year":"2010","journal-title":"Minerva Endocrinol."},{"issue":"11","key":"10.1016\/j.gene.2016.04.031_bb0100","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1684\/bdc.2011.1466","article-title":"Hormone therapy and breast cancer","volume":"98","author":"de Cremoux","year":"2011","journal-title":"Bull. Cancer"},{"issue":"4","key":"10.1016\/j.gene.2016.04.031_bb0105","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-05-3574","article-title":"Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies","volume":"66","author":"Feigelson","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0110","first-page":"785","article-title":"Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates","volume":"61","author":"Feigelson","year":"2001","journal-title":"Cancer Res."},{"issue":"28","key":"10.1016\/j.gene.2016.04.031_bb0115","doi-asserted-by":"crossref","first-page":"25677","DOI":"10.1074\/jbc.M202160200","article-title":"Critical residues for structure and catalysis in short-chain dehydrogenases\/reductases","volume":"277","author":"Filling","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.gene.2016.04.031_bb0120","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1021\/jm701447v","article-title":"Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases","volume":"51","author":"Frotscher","year":"2008","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1096\/fj.02-0397fje","article-title":"Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase","volume":"17","author":"Gangloff","year":"2003","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.gene.2016.04.031_bb0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0969-2126(01)00183-6","article-title":"Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20A resolution","volume":"3","author":"Ghosh","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.gene.2016.04.031_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1749-6632.1995.tb31388.x","article-title":"Molecular mechanism of inhibition of steroid dehydrogenases by licorice-derived steroid analogs in modulation of steroid receptor function","volume":"761","author":"Ghosh","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1\u20133","key":"10.1016\/j.gene.2016.04.031_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0009-2797(00)00255-6","article-title":"Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17beta-hydroxysteroid dehydrogenase 1","volume":"130\u2013132","author":"Ghosh","year":"2001","journal-title":"Chem. Biol. Interact."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0290","first-page":"66","article-title":"17\u03b2-Hydroxysteroid dehydrogenases (17\u03b2-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development","volume":"125","author":"Hartmann","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.gene.2016.04.031_bb0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/0008-5472.CAN-04-2694","article-title":"Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands","volume":"65","author":"Hershberger","year":"2005","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.gene.2016.04.031_bb0150","first-page":"2010","article-title":"Critical residues for the specificity of cofactors and substrates in human estrogenic 17beta-hydroxysteroid dehydrogenase 1: variants designed from the three-dimensional structure of the enzyme","volume":"15","author":"Huang","year":"2001","journal-title":"Mol. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2005.11.042","article-title":"Evaluation of inhibitors for 17beta-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme","volume":"248","author":"Husen","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.gene.2016.04.031_bb0160","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1074\/jbc.M411751200","article-title":"Mechanistic roles of Ser-114, Tyr-155, and Lys-159 in 3alpha-hydroxysteroid dehydrogenase\/carbonyl reductase from Comamonas testosteroni","volume":"280","author":"Hwang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsbmb.2008.12.012","article-title":"17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer","volume":"114","author":"Jansson","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/bbrc.1999.0704","article-title":"Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH","volume":"259","author":"Jin","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.gene.2016.04.031_bb0175","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1016\/S0021-9258(18)62799-1","article-title":"Human placental 17 beta-estradiol dehydrogenase. V. Purification and partial characterization of the diphosphopyridine nucleotide (triphosphopyridine nucleotide)-linked enzyme","volume":"245","author":"Karavolas","year":"1970","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.gene.2016.04.031_bb0180","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.pgen.0010068","article-title":"Genetic variation in the HSD17B1 gene and risk of prostate cancer","volume":"1","author":"Kraft","year":"2005","journal-title":"PLoS Genet."},{"issue":"9 Suppl 1","key":"10.1016\/j.gene.2016.04.031_bb0185","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.amjmed.2006.07.030","article-title":"Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife","volume":"119","author":"Kravitz","year":"2006","journal-title":"Am. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0027-5107(01)00212-3","article-title":"Genetic susceptibility and environmental estrogen-like compounds","volume":"482","author":"Kristensen","year":"2001","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.gene.2016.04.031_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0250001","article-title":"Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease","volume":"25","author":"Labrie","year":"2000","journal-title":"J. Mol. Endocrinol."},{"issue":"33","key":"10.1016\/j.gene.2016.04.031_bb0200","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.0505575102","article-title":"From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response","volume":"102","author":"Lagani\u00e8re","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.gene.2016.04.031_bb0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0021-9258(18)64708-8","article-title":"Human placental estradiol-17 beta dehydrogenase. I. Concentration, characterization and assay","volume":"233","author":"Langer","year":"1958","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2008.08.026","article-title":"Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors","volume":"301","author":"Laplante","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.gene.2016.04.031_bb0215","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1021\/jm049045r","article-title":"Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors","volume":"48","author":"Lawrence","year":"2005","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.gene.2016.04.031_bb0220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.placenta.2004.07.008","article-title":"Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase, and 17beta-hydroxysteroid dehydrogenase types 1, 2, 5 and 7 mRNAs in human early and mid-gestation placentas","volume":"26","author":"Li","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.gene.2016.04.031_bb0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jsbmb.2003.09.013","article-title":"Expression of P450 aromatase and 17\u03b2-hydroxysteroid dehydrogenase type 1 at fetal-maternal interface during tubal pregnancy","volume":"87","author":"Li","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.gene.2016.04.031_bb0230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0960-0760(99)00062-X","article-title":"3D-structure of human estrogenic 17beta-HSD1: binding with various steroids","volume":"69","author":"Lin","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.gene.2016.04.031_bb0235","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2174\/15680266113139990004","article-title":"A challenge for medicinal chemistry by the 17\u03b2-hydroxysteroid dehydrogenase superfamily: an integrated biological function and inhibition study","volume":"13","author":"Lin","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"issue":"23","key":"10.1016\/j.gene.2016.04.031_bb0240","doi-asserted-by":"crossref","first-page":"16182","DOI":"10.1016\/S0021-9258(18)41984-9","article-title":"Subunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta","volume":"267","author":"Lin","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"Suppl","key":"10.1016\/j.gene.2016.04.031_bb0245","first-page":"S13","article-title":"Studies on the three-dimensional structure of estrogenic 17 beta-hydroxysteroid dehydrogenase","volume":"150","author":"Lin","year":"1996","journal-title":"J. Endocrinol."},{"issue":"9 Suppl 1","key":"10.1016\/j.gene.2016.04.031_bb0250","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amjmed.2006.07.009","article-title":"The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife","volume":"119","author":"Lo","year":"2006","journal-title":"Am. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2005.12.007","article-title":"Structure and function of human 17beta-hydroxysteroid dehydrogenases","volume":"248","author":"Lukacik","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.gene.2016.04.031_bb0260","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1210\/mend-3-8-1301","article-title":"Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5\u2032-termini in human placenta","volume":"3","author":"Luu-The","year":"1989","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.gene.2016.04.031_bb0265","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1210\/endo-123-3-1281","article-title":"The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells","volume":"123","author":"MacIndoe","year":"1988","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.gene.2016.04.031_bb0270","first-page":"582","article-title":"Immunohistochemical localization of 17 beta-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle","volume":"65","author":"M\u00e4entausta","year":"1991","journal-title":"Lab. Investig."},{"issue":"9","key":"10.1016\/j.gene.2016.04.031_bb0275","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1021\/ml200093v","article-title":"Crucial role of 3-bromoethyl in removing the estrogenic activity of 17\u03b2-HSD1 inhibitor 16\u03b2-(m-carbamoylbenzyl)estradiol","volume":"2","author":"Maltais","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.gene.2016.04.031_bb0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm401639v","article-title":"Discovery of a non-estrogenic irreversible inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type 1 from 3-substituted-16\u03b2-(m-carbamoylbenzyl)-estradiol derivatives","volume":"57","author":"Maltais","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.gene.2016.04.031_bb0285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/BJ20091020","article-title":"Binary and ternary crystal structure analyses of a novel inhibitor of 17\u03b2-HSD type1: a lead compound for breast cancer therapy","volume":"424","author":"Marchais-Oberwinkler","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2016.04.031_bb2000","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/BJ20091020","article-title":"Binary and ternary crystal structure analyses of a novel inhibitor of 17\u03b2-HSD type1: a lead compound for breast cancer therapy","volume":"424","author":"Mazumdar","year":"2009","journal-title":"Biochem. J."},{"issue":"4\u20135","key":"10.1016\/j.gene.2016.04.031_bb0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2009.07.004","article-title":"Ligand-based NMR spectra demonstrate an additional phytoestrogen binding site for 17beta-hydroxysteroid dehydrogenase type 1","volume":"117","author":"Michiels","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.gene.2016.04.031_bb0300","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cmdc.201402050","article-title":"6-Hydroxybenzothiophene ketones: potent inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type1 (17\u03b2-HSD1) owing to favorable molecule geometry and conformational preorganization","volume":"9","author":"Miralinaghi","year":"2014","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.gene.2016.04.031_bb0305","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ijc.1525","article-title":"Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers","volume":"94","author":"Miyoshi","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.gene.2016.04.031_bb0310","doi-asserted-by":"crossref","first-page":"e12026","DOI":"10.1371\/journal.pone.0012026","article-title":"Insights in 17beta-HSD1 enzyme kinetics and ligand binding by dynamic motion investigation","volume":"5","author":"Negri","year":"2010","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0315","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00665786","article-title":"Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020)","volume":"34","author":"Nguyen","year":"1995","journal-title":"Breast Cancer Res. Treat."},{"issue":"2\u20135","key":"10.1016\/j.gene.2016.04.031_bb0320","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2005.02.007","article-title":"Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer","volume":"93","author":"Pasqualini","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.gene.2016.04.031_bb0325","first-page":"1460","article-title":"Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients","volume":"81","author":"Pasqualini","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20136","key":"10.1016\/j.gene.2016.04.031_bb0330","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-4731(89)90077-0","article-title":"Importance of estrogen sulfates in breast cancer","volume":"34","author":"Pasqualini","year":"1989","journal-title":"J. Steroid Biochem."},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0335","first-page":"123","article-title":"The selective estrogen enzyme modulators in breast cancer: a review","volume":"1654","author":"Pasqualini","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.gene.2016.04.031_bb0340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(88)80548-9","article-title":"Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA","volume":"239","author":"Peltoketo","year":"1988","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gene.2016.04.031_bb0345","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/erc.0.0030041","article-title":"17\u03b2-hydroxysteroid dehydrogenase: inhibitors and inhibitors design","volume":"3","author":"Penning","year":"1996","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.gene.2016.04.031_bb0350","first-page":"281","article-title":"Molecular endocrinology of hydroxysteroid dehydrogenases","volume":"18","author":"Penning","year":"1997","journal-title":"Endocr. Rev."},{"issue":"9","key":"10.1016\/j.gene.2016.04.031_bb0355","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1517\/13543776.2010.505604","article-title":"17beta-hydroxysteroid dehydrogenase inhibitors: a patent review","volume":"20","author":"Poirier","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/j.gene.2016.04.031_bb0360","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2174\/187152009788680000","article-title":"Advances in development of inhibitors of 17beta hydroxysteroid dehydrogenases","volume":"9","author":"Poirier","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsbmb.2010.12.007","article-title":"Contribution to the development of inhibitors of 17\u03b2-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases","volume":"125","author":"Poirier","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.gene.2016.04.031_bb0370","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/0929867033368222","article-title":"Inhibitors of 17 beta-hydroxysteroid dehydrogenases","volume":"10","author":"Poirier","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.gene.2016.04.031_bb0375","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1081\/SCC-120023440","article-title":"Synthesis of a First Estradiol- Adenosine Hybrid Compound","volume":"33","author":"Poirier","year":"2003","journal-title":"Synth. Commun."},{"issue":"5\u20136","key":"10.1016\/j.gene.2016.04.031_bb0380","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0960-0760(95)00201-4","article-title":"Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis","volume":"55","author":"Poutanen","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"Pt 1","key":"10.1016\/j.gene.2016.04.031_bb0385","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj3040289","article-title":"Site-directed mutagenesis of the putative active site of human 17\u03b2-hydroxysteroid dehydrogenase type 1","volume":"304","author":"Puranen","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2016.04.031_bb0390","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1096\/fj.02-0026fje","article-title":"A concerted, rational design of 17beta-hydroxysteroid dehydrogenase inhibitors: complex structure with estradiol-adenosine hybrids with high affinity","volume":"16","author":"Qiu","year":"2002","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.gene.2016.04.031_bb0395","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2353\/ajpath.2010.090325","article-title":"Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice","volume":"176","author":"Saloniemi","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.gene.2016.04.031_bb0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/jcem-59-1-29","article-title":"In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway","volume":"59","author":"Santner","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3\u20135","key":"10.1016\/j.gene.2016.04.031_bb0405","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jsbmb.2007.09.012","article-title":"Intracrinology of estrogens and androgens in breast carcinoma","volume":"108","author":"Sasano","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.gene.2016.04.031_bb0410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0303-7207(00)00431-7","article-title":"Expression of the estradiol-synthesizing 17beta-hydroxysteroid dehydrogenases type 1 and type 7 in the nonhuman primate Callithrix jacchus","volume":"171","author":"Schwabe","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0415","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1158\/1055-9965.EPI-03-0241","article-title":"HSD17B1 gene polymorphisms and risk of endometrial and breast cancer","volume":"13","author":"Setiawan","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.gene.2016.04.031_bb0420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mce.2006.12.021","article-title":"Cofactors, redox state, and directional preferences of hydroxysteroid dehydrogenases","volume":"265\u2013266","author":"Sherbet","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.gene.2016.04.031_bb0425","first-page":"16678","article-title":"Cofactor hydrogen bonding onto the protein main chain is conserved in the short-chain dehydrogenase\/reductase family and contributes to nicotinamide orientation","volume":"271","author":"Shi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.gene.2016.04.031_bb0430","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-007-9788-0","article-title":"Oestrogen producing enzymes and mammary carcinogenesis: a review","volume":"111","author":"Subramanian","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.gene.2016.04.031_bb0435","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00795-007-0365-8","article-title":"In situ production of sex steroids in human breast carcinoma","volume":"40","author":"Suzuki","year":"2007","journal-title":"Med. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.gene.2016.04.031_bb0440","first-page":"410","article-title":"17beta-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus","volume":"85","author":"Takeyama","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2016.04.031_bb0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1479-5876-11-167","article-title":"Intratumoral localization and activity of 17\u03b2-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor","volume":"11","author":"Verma","year":"2013","journal-title":"J. Transl. Med."},{"issue":"3\u20135","key":"10.1016\/j.gene.2016.04.031_bb0450","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsbmb.2011.07.013","article-title":"Sex steroid receptors in human lung diseases","volume":"127","author":"Verma","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.gene.2016.04.031_bb0455","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.10957","article-title":"HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore","volume":"104","author":"Wu","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gene.2016.04.031_bb0460","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-4347(92)80304-9","article-title":"Rapid purification yielding highly active 17beta-hydroxysteroid dehydrogenase: application of hydrophobic interaction and affinity fast protein liquid chromatography","volume":"582","author":"Yang","year":"1992","journal-title":"J. Chromatogr."},{"issue":"1","key":"10.1016\/j.gene.2016.04.031_bb0465","doi-asserted-by":"crossref","first-page":"e29835","DOI":"10.1371\/journal.pone.0029835","article-title":"The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2016.04.031_bb0470","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jsbmb.2014.09.017","article-title":"Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells","volume":"150","author":"Zhang","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.gene.2016.04.031_bb0475","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/jmbi.1993.1578","article-title":"Crystallization and preliminary X-ray diffraction analysis of the complex of human placental 17beta-hydroxysteroid dehydrogenase with NADP+","volume":"234","author":"Zhu","year":"1993","journal-title":"J. Mol. Biol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111916303018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111916303018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T12:22:07Z","timestamp":1655554927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111916303018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0378111916303018"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2016.04.031","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge of the multifunctional 17\u03b2-hydroxysteroid dehydrogenase type 1 (HSD17B1)","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2016.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}